Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Benchtop Ultracentrifuge is Fast, Quiet, and Easy-to-Use

By HospiMedica staff writers
Posted on 19 Sep 2007
A new benchtop ultracentrifuge delivers fast run times of up to 150,000 RPM (2,500 revolutions per second) and is exceptionally quiet--producing only half the sound power of other benchtop models.

The ultracentrifuge, called the Optima MAX-XP, features a new MLA-150 fixed-angle rotor that has a low k-factor for rapid separation of small volume samples such as subcellular particles, viruses, and proteins. More...
The software has significant ease-of-use enhancements: the user interface is intuitive and customizable with control via a full-color touch screen. Optional remote monitoring and control of the system is also available. Users can easily switch between revolutions per minute (RPM) and relative centrifugal force (RCF) modes. Important data, including detailed run histories, can be easily exported through a USB port. The software supports quality control (21CFR Part 11, GLP and GMP) compliance and new user ID and login features provide important lab management tools.

Launched by Beckman Coulter (Nyon, Switzerland), the Optima MAX-XP is offered with multiple levels of biocontainment and is designed to fit in a standard biosafety hood. For added protection, this new ultracentrifuge is also offered in a biosafe version featuring high efficiency particle arresting (HEPA) filtration. A selection of labware and rotors for biosafety requirements is available, and all existing Optima MAX and Optima TLX rotors are compatible with the new ultracentrifuge.


Related Links:
Beckman Coulter

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.